It is almost a given, they are rarely denied a patent in these circumstances.
In regards to 510K easier to post a link
https://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/510kClearances/default.htm
The costs etc to do with having a "generic" ReCell are many especially with a device like ReCell much more than a medicine which is a simple formula. Molds for the device which are expensive to design, make and the testing of the device working the same, it's not as bad as all th full clinical trials etc, but, it's just a lot more money, risk etc for something where the majority of the US market will be closed to them. I don't see it being worth it.
- Forums
- ASX - By Stock
- AVH
- Patent extension
AVH
avita medical inc.
Add to My Watchlist
2.26%
!
$1.81

Patent extension, page-29
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.81 |
Change
0.040(2.26%) |
Mkt cap ! $128.9M |
Open | High | Low | Value | Volume |
$1.79 | $1.83 | $1.77 | $166.2K | 92.24K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 17378 | $1.78 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.81 | 254 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 17378 | 1.780 |
3 | 2840 | 1.760 |
1 | 20000 | 1.755 |
6 | 38898 | 1.750 |
2 | 1993 | 1.720 |
Price($) | Vol. | No. |
---|---|---|
1.810 | 254 | 1 |
1.830 | 546 | 1 |
1.840 | 3278 | 1 |
1.855 | 1000 | 1 |
1.860 | 1516 | 1 |
Last trade - 16.10pm 15/07/2025 (20 minute delay) ? |
Featured News
AVH (ASX) Chart |
The Watchlist
CC9
CHARIOT CORPORATION LTD
Shanthar Pathmanathan, MD
Shanthar Pathmanathan
MD
Previous Video
Next Video
SPONSORED BY The Market Online